| pubmed-article:21651426 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21651426 | lifeskim:mentions | umls-concept:C0016053 | lld:lifeskim |
| pubmed-article:21651426 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21651426 | lifeskim:mentions | umls-concept:C0245561 | lld:lifeskim |
| pubmed-article:21651426 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:21651426 | lifeskim:mentions | umls-concept:C0041703 | lld:lifeskim |
| pubmed-article:21651426 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21651426 | pubmed:dateCreated | 2011-7-7 | lld:pubmed |
| pubmed-article:21651426 | pubmed:abstractText | To evaluate the cost effectiveness of duloxetine when considered as an alternative treatment for patients in the United States (US) being treated for fibromyalgia pain. | lld:pubmed |
| pubmed-article:21651426 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21651426 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21651426 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21651426 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21651426 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21651426 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21651426 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21651426 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21651426 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21651426 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21651426 | pubmed:issn | 1941-837X | lld:pubmed |
| pubmed-article:21651426 | pubmed:author | pubmed-author:ColemanAA | lld:pubmed |
| pubmed-article:21651426 | pubmed:author | pubmed-author:ZhaiSS | lld:pubmed |
| pubmed-article:21651426 | pubmed:author | pubmed-author:LawsonKK | lld:pubmed |
| pubmed-article:21651426 | pubmed:author | pubmed-author:BOYRR | lld:pubmed |
| pubmed-article:21651426 | pubmed:author | pubmed-author:LiT GTG | lld:pubmed |
| pubmed-article:21651426 | pubmed:author | pubmed-author:BeardS MSM | lld:pubmed |
| pubmed-article:21651426 | pubmed:author | pubmed-author:RoskellNN | lld:pubmed |
| pubmed-article:21651426 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21651426 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:21651426 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21651426 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21651426 | pubmed:pagination | 463-76 | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:meshHeading | pubmed-meshheading:21651426... | lld:pubmed |
| pubmed-article:21651426 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21651426 | pubmed:articleTitle | Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States. | lld:pubmed |
| pubmed-article:21651426 | pubmed:affiliation | RTI Health Solutions, Manchester, UK. sbeard@rti.org | lld:pubmed |
| pubmed-article:21651426 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21651426 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
